Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.

Tajmohammadi A, Razavi BM, Hosseinzadeh H.

Phytother Res. 2018 Oct;32(10):1933-1949. doi: 10.1002/ptr.6153. Epub 2018 Jul 17. Review.

PMID:
30015401
2.

Role of silibinin in the management of diabetes mellitus and its complications.

Chu C, Li D, Zhang S, Ikejima T, Jia Y, Wang D, Xu F.

Arch Pharm Res. 2018 Aug;41(8):785-796. doi: 10.1007/s12272-018-1047-x. Epub 2018 Jul 6. Review.

PMID:
29978427
3.

Effects of silymarin on metabolic syndrome: a review.

Vahabzadeh M, Amiri N, Karimi G.

J Sci Food Agric. 2018 Oct;98(13):4816-4823. doi: 10.1002/jsfa.9115. Epub 2018 Jun 27. Review.

PMID:
29736939
4.

Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis.

Sridharan K, Sivaramakrishnan G.

Expert Rev Clin Pharmacol. 2018 Jun;11(6):641-650. doi: 10.1080/17512433.2018.1473760. Epub 2018 May 18. Review.

PMID:
29727586
5.

Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases.

Taleb A, Ahmad KA, Ihsan AU, Qu J, Lin N, Hezam K, Koju N, Hui L, Qilong D.

Biomed Pharmacother. 2018 Jun;102:689-698. doi: 10.1016/j.biopha.2018.03.140. Epub 2018 Apr 5. Review.

PMID:
29604588
6.

Silymarin: An interesting modality in dermatological therapeutics.

Dorjay K, Arif T, Adil M.

Indian J Dermatol Venereol Leprol. 2018;84(2):238-243. doi: 10.4103/ijdvl.IJDVL_746_16. Review. No abstract available.

7.

The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials.

Zhong S, Fan Y, Yan Q, Fan X, Wu B, Han Y, Zhang Y, Chen Y, Zhang H, Niu J.

Medicine (Baltimore). 2017 Dec;96(49):e9061. doi: 10.1097/MD.0000000000009061.

8.

Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis.

de Avelar CR, Pereira EM, de Farias Costa PR, de Jesus RP, de Oliveira LPM.

World J Gastroenterol. 2017 Jul 21;23(27):5004-5017. doi: 10.3748/wjg.v23.i27.5004. Review.

9.

Targeting STAT3 with silibinin to improve cancer therapeutics.

Bosch-Barrera J, Queralt B, Menendez JA.

Cancer Treat Rev. 2017 Jul;58:61-69. doi: 10.1016/j.ctrv.2017.06.003. Epub 2017 Jun 23. Review.

PMID:
28686955
10.

Silymarin impacts on immune system as an immunomodulator: One key for many locks.

Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B.

Int Immunopharmacol. 2017 Sep;50:194-201. doi: 10.1016/j.intimp.2017.06.030. Epub 2017 Jun 30. Review.

PMID:
28672215
11.

The Role of Polyphenols in Rosacea Treatment: A Systematic Review.

Saric S, Clark AK, Sivamani RK, Lio PA, Lev-Tov HA.

J Altern Complement Med. 2017 Dec;23(12):920-929. doi: 10.1089/acm.2016.0398. Epub 2017 Jun 26. Review.

PMID:
28650692
12.

Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review.

Suraweera D, Rahal H, Jimenez M, Viramontes M, Choi G, Saab S.

Liver Int. 2017 Dec;37(12):1877-1886. doi: 10.1111/liv.13477. Epub 2017 Jun 14. Review.

PMID:
28517369
13.

Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.

Lombardi R, Onali S, Thorburn D, Davidson BR, Gurusamy KS, Tsochatzis E.

Cochrane Database Syst Rev. 2017 Mar 30;3:CD011640. doi: 10.1002/14651858.CD011640.pub2. Review.

PMID:
28358980
14.

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.

Federico A, Dallio M, Loguercio C.

Molecules. 2017 Jan 24;22(2). pii: E191. doi: 10.3390/molecules22020191. Review.

15.

Effects of Silymarin on Diabetes Mellitus Complications: A Review.

Stolf AM, Cardoso CC, Acco A.

Phytother Res. 2017 Mar;31(3):366-374. doi: 10.1002/ptr.5768. Epub 2017 Jan 25. Review.

PMID:
28124457
16.

A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin.

Devi KP, Malar DS, Braidy N, Nabavi SM, Nabavi SF.

Curr Drug Targets. 2017;18(13):1529-1536. doi: 10.2174/1389450117666161227125121. Review.

PMID:
28025940
17.

Silymarin and Its Role in Chronic Diseases.

Neha, Jaggi AS, Singh N.

Adv Exp Med Biol. 2016;929:25-44. Review.

PMID:
27771919
18.

The Potential of Flavonolignans in Prostate Cancer Management.

Vue B, Chen QH.

Curr Med Chem. 2016;23(34):3925-3950. Review.

PMID:
27557939
19.

Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review.

Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, Gu N, Wu J, Li W, Zhang Y, Zhou S, Sun H, Liu C.

Eur J Med Chem. 2016 Nov 10;123:577-595. doi: 10.1016/j.ejmech.2016.07.070. Epub 2016 Jul 29. Review.

PMID:
27517806
20.

May Patients with Alcohol Liver Disease Benefit from Herbal Medicines?

Milosevic N, Milanovic M, Turkulov V, Medić-Stojanoska M, Abenavoli L, Milic N.

Rev Recent Clin Trials. 2016;11(3):227-37. Review.

PMID:
27457345

Supplemental Content

Loading ...
Support Center